Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Efficacy of Salbutamol (Sandoz) Versus Salbutamol Ventolin (GSK) in Children With Asthma

NCT05884970 is registered in ClinicalTrials.gov with Canisius-Wilhelmina Hospital as lead sponsor.

NCT NCT05884970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Efficacy of Salbutamol (Sandoz) Versus Salbutamol Ventolin (GSK) in Children With Asthma
Lead sponsor
Canisius-Wilhelmina Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
March 30, 2023
Completion date
September 30, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agents, anti asthmatic, asthma in children